Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Mailman

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Journal of Medicinal Chemistry|September 1, 1989
Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligandsP S Charifson, J P Bowen, S D Wyrick, et al.
Synapse (New York, N.Y.)|October 1, 1995
Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonistsV J Watts, C P Lawler, A J Gonzales, et al.
Biological Psychiatry|June 1, 1984
Thioridazine and the neuroleptic radioreceptor assayR B Mailman, J P Pierce, K M Crofton, et al.
European Journal of Pharmacology|August 3, 1993
Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligandsV J Watts, C P Lawler, T Knoerzer, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Increase in dopamine metabolites in rat brain by neurotensinE Widerlöv, C D Kilts, R B Mailman, et al.
Journal of Medicinal Chemistry|June 1, 1990
trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonistW K Brewster, D E Nichols, R M Riggs, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1981
Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanolG D Frye, R E Chapin, R A Vogel, et al.
Journal of Medicinal Chemistry|October 1, 1988
Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligandsP S Charifson, S D Wyrick, A J Hoffman, et al.
European Journal of Pharmacology|July 19, 1991
Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeysJ R Taylor, M S Lawrence, D E Redmond, et al.
Advances in Experimental Medicine and Biology|January 1, 1980
A comparison of behavioral and neurochemical effects of ethanol and chlordiazepoxideG D Frye, R A Vogel, R B Mailman, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|September 1, 1989
Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligandsP S Charifson, J P Bowen, S D Wyrick, et al.
Synapse (New York, N.Y.)|October 1, 1995
Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonistsV J Watts, C P Lawler, A J Gonzales, et al.
Biological Psychiatry|June 1, 1984
Thioridazine and the neuroleptic radioreceptor assayR B Mailman, J P Pierce, K M Crofton, et al.
European Journal of Pharmacology|August 3, 1993
Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligandsV J Watts, C P Lawler, T Knoerzer, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Increase in dopamine metabolites in rat brain by neurotensinE Widerlöv, C D Kilts, R B Mailman, et al.
Journal of Medicinal Chemistry|June 1, 1990
trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonistW K Brewster, D E Nichols, R M Riggs, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1981
Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanolG D Frye, R E Chapin, R A Vogel, et al.
Journal of Medicinal Chemistry|October 1, 1988
Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligandsP S Charifson, S D Wyrick, A J Hoffman, et al.
European Journal of Pharmacology|July 19, 1991
Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeysJ R Taylor, M S Lawrence, D E Redmond, et al.
Advances in Experimental Medicine and Biology|January 1, 1980
A comparison of behavioral and neurochemical effects of ethanol and chlordiazepoxideG D Frye, R A Vogel, R B Mailman, et al.
Pageof 16